Sofinnova BioEquities Enhanced Master Fund, LP

CIK 1949475 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sofinnova BioEquities Enhanced Master Fund, LP.

Recent SEC filings

FiledFormAccession number
Oct 10, 2025D/A0000919574-25-006040
Oct 11, 2024D/A0000919574-24-005846
Oct 13, 2023D/A0000919574-23-005656
Oct 13, 2022D0000919574-22-005947